Jerónimo Rafael Rodríguez‐Cid

机构：Hospital Médica Sur, Instituto Nacional de Neurología y Neurocirugía · ORCID：0000-0001-8518-9065

发表论文 76 篇 · 总被引 7600 次 · h-index 17

代表论文

• Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study (2023 · Journal of Clinical Oncology · 被引 540)
• Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 154)
• Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA (2024 · Annals of Oncology · 被引 87)
• OA13.03 Perioperative Durvalumab for Resectable NSCLC (R-NSCLC): Updated Outcomes from the Phase 3 AEGEAN Trial (2024 · Journal of Thoracic Oncology · 被引 25)
• Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications (2023 · Frontiers in Oncology · 被引 14)
• Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico (2024 · PharmacoEconomics - Open · 被引 4)